Comparative Study Matching Intraperitoneal Onlay Mesh (IPOM) and Sublay Mesh to Treat Umbilical Hernia

Prospective Randomized Multicenter Trial Comparing Laparoscopic (IPOM) vs. Sublay Mesh Plasty for Umbilical Hernia in Adults

This study is designed to compare two techniques for operative care of umbilical hernia in adults regarding wound complications, wound side fluid collections, recurrence rate, postoperative pain, duration of hospitalization and quality of life. The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind the rectus muscle after small incision close to the belly button.

Study Overview

Study Type

Interventional

Enrollment (Actual)

306

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Niedersachsen
      • Rotenburg, Niedersachsen, Germany, 27356
        • Diakoniekrankenhaus Rotenburg (Wuemme) gGmbH
      • Basel, Switzerland, 4031
        • University Hospital Basel
      • Luzern, Switzerland, 6000
        • Luzerner Kantonsspital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • informed consent
  • patient age: ≥ 18 years
  • elective surgery for umbilical hernia
  • hernia diameter ≥ 1cm

Exclusion Criteria:

  • previous history of median laparotomy
  • navel site infection
  • contraindication for general anaesthesia
  • American Society of Anesthesiologists (ASA) score >IV
  • pregnancy
  • cirrhosis of the liver (CHILD B and C) and/or ascites
  • cytostatic therapy
  • incarcerated hernia
  • recurrent hernia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: intraperitoneal onlay mesh repair
The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind des rectus muscle after small incision close to the belly button.
Active Comparator: sublay mesh repair
The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind des rectus muscle after small incision close to the belly button.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
early wound complications
Time Frame: 30 days after operation
  • wound infection (with or without removal of the mesh)
  • wound necrosis
  • wound hematoma
30 days after operation
late wound complications
Time Frame: 1 year after operation
  • wound infection (with or without removal of the mesh)
  • wound necrosis
  • wound hematoma
1 year after operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complication rate perioperative
Time Frame: intraoperative complications will be recorded immediately after finishing the operation
  • major bleeding
  • bowel injury
intraoperative complications will be recorded immediately after finishing the operation
duration of operation
Time Frame: the duration will be recorded immediately after finishing the operation
measured in minutes according to operations protocol (duration cut - suture)
the duration will be recorded immediately after finishing the operation
hospital stay
Time Frame: will be measured after discharge of the patient
measured in days
will be measured after discharge of the patient
umbilical hernia recurrence rate
Time Frame: 30 days
the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
30 days
umbilical hernia recurrence rate
Time Frame: 1 year
the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
1 year
umbilical hernia recurrence rate
Time Frame: 3 years
the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
3 years
umbilical hernia recurrence rate
Time Frame: 5 years
the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
5 years
navel site seroma
Time Frame: discharge day
the diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
discharge day
navel site seroma
Time Frame: after 30 days
the diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
after 30 days
navel site seroma
Time Frame: after 1 year
the diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
after 1 year
complication rate postoperative
Time Frame: 30 day
  • trocar site hernia
  • enteral fistula
  • persistent pain
  • re-operation
30 day
complication rate postoperative
Time Frame: 1 year
  • trocar site hernia
  • enteral fistula
  • persistent pain
  • re-operation
1 year
complication rate postoperative
Time Frame: 3 years
  • trocar site hernia
  • enteral fistula
  • persistent pain
  • re-operation
3 years
complication rate postoperative
Time Frame: 5 years
  • trocar site hernia
  • enteral fistula
  • persistent pain
  • re-operation
5 years
pain score (Visual Analog Scale - VAS)
Time Frame: 24h post operative
will be measured by the nurse according to Visual Analog Scale
24h post operative
pain score (Visual Analog Scale - VAS)
Time Frame: 48h post operative
will be measured by the nurse according to Visual Analog Scale
48h post operative
pain score (Visual Analog Scale - VAS)
Time Frame: immediately before discharge
will be measured by the nurse according to Visual Analog Scale
immediately before discharge
Quality of life (SF-36)
Time Frame: 1 day pre-operative
patients will be asked to fulfill validated SF-36 questionnaire
1 day pre-operative
Quality of life (SF-36)
Time Frame: 30 days postoperatively
patients will be asked to fulfill validated SF-36 questionnaire
30 days postoperatively
Quality of life (SF-36)
Time Frame: 1 year postoperatively
patients will be asked to fulfill validated SF-36 questionnaire
1 year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Daniel Oertli, Professor, Departement of General Surgery, University Hospital Basel, Switzerland
  • Study Director: Oleg Heizmann, MD, Departement of General,- Visceral- and Thoracic Surgery, Diakoniekrankenhaus Rotenburg (Wuemme), Germany
  • Principal Investigator: Daniel Matz, MD, Departement of General,- Visceral- and Thoracic Surgery, Diakoniekrankenhaus Rotenburg (Wuemme), Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

July 19, 2010

First Submitted That Met QC Criteria

September 13, 2010

First Posted (Estimate)

September 14, 2010

Study Record Updates

Last Update Posted (Actual)

May 7, 2019

Last Update Submitted That Met QC Criteria

May 6, 2019

Last Verified

May 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Umbilical Hernia

Clinical Trials on intraperitoneal onlay mesh repair

Subscribe